AnaptysBio Inc Cash Flow Reinvestment Rate
AnaptysBio Inc cash flow reinvestment rate. AnaptysBio Inc (ANAB) has a Cash Flow Reinvestment Rate of 0.75x as of December 2025, reinvesting $73.50 Million (capex $1.00K plus investments $73.50 Million) from operating cash flow of $98.00 Million. Explore ANAB operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of AnaptysBio Inc (2014–2025)
Cash flow reinvestment rate of AnaptysBio Inc from 2014 to 2025. Historical reinvestment intensity for AnaptysBio Inc across 2 annual periods. Explore ANAB capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
AnaptysBio Inc Cash Flow Reinvestment Rate by Year (2014–2025)
AnaptysBio Inc cash flow reinvestment rate by year from 2014 to 2025. Year-by-year capital reinvestment analysis for AnaptysBio Inc. For the full cash flow conversion analysis, see how efficiently does AnaptysBio Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 11.59x | $228.21 Million | $19.70 Million | $87.00K | ▼ -30.4% |
| 2014 | 16.63x | $242.91 Million | $14.60 Million | $145.00K | — |